• Company
  • News
  • Investors
  • Contacts
  • Careers
polypeptide-logopolypeptide-logologo-mobilepolypeptide-logo
  • Services
    • GMP Compliance
    • Pre-GMP development
    • Production
    • Quality Assurance
    • Quality control
    • Regulatory Support
  • Commercial Manufacturing
    • Commercial products at PolyPeptide
    • Late stage development
    • Process development and optimization
    • Capacity and Capabilities
  • Custom R&D
    • Custom Research Grade Peptides
    • Radiolabeled peptide
  • Generic peptides
  • Services
    • GMP Compliance
    • Pre-GMP development
    • Production
    • Quality Assurance
    • Quality control
    • Regulatory Support
  • Commercial Manufacturing
    • Commercial products at PolyPeptide
    • Late stage development
    • Process development and optimization
    • Capacity and Capabilities
  • Custom R&D
    • Custom Research Grade Peptides
    • Radiolabeled peptide
  • Generic peptides
✕
  • Home
  • News
  • Expert views
  • Downstream Processes for peptide manufacturing: Optimization strategy and latest technical trends

Downstream Processes for peptide manufacturing: Optimization strategy and latest technical trends

2 April 2021
Expert views

This article highlights the key steps in the development and implementation of a proper purification strategy for the manufacture of peptide APIs. Our ambition is to recommend a structured methodology, including a good understanding of the separation mechanism to develop the process and to apply the latest technologies for the optimization of the purification step to reach the best performance of the manufacturing process. […]

Purification is a critical unit operation in the manufacturing route of a peptide. Its optimization requires the expertise of the chromatographer together with the skills of process engineers to select  the most suitable solution to produce peptide APIs. The selection of the chromatographic conditions is of paramount importance, and an appropriate expertise and methodology are crucial to  propose the appropriate process development strategy throughout the clinical trials. Mastering the latest technologies also offers great opportunities for the implementation of an efficient and
reliable process.

2/2021 – April, OLIVIER LUDEMANN-HOMBOURGER1, PER MÖLLER, FRANCOIS KUSTER

Read more

Back to news

Related posts

19 December 2025

PolyPeptide showcases leadership in sustainable peptide manufacturing with two landmark publications


Read more
27 November 2025

PolyPeptide’s Approach to Process Intensification: Tackling the increasing Peptide Demand


Read more
13 August 2025

Backbone Protecting Groups for Enhanced Peptide and Protein Synthesis


Read more

Polypeptide Group

INFO

COMPANY
LEADERSHIP
CONTACTS
CAREERS

NEWS

LATEST NEWS
SIGN UP FOR NEWS
EVENTS

SOCIALS

LINKEDIN
YOUTUBE
© Confidentiality 2026 PolyPeptide Group • Cookie Policy • Sitemap • Privacy policy
    • Company
    • News
    • Investors
    • Contacts
    • Careers